Skip to content

Neurocognitive Effects of Meal Timing in a One-Meal-a-Day Regimen

Synergistic Effects of Green Tea Extract and Ginger Supplementation on Endurance Performance and Thermal Perception in Normal and Cold Environments: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07181057
Acronym
OMAD
Enrollment
12
Registered
2025-09-18
Start date
2025-03-01
Completion date
2025-05-15
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Abilities, Fasting State

Brief summary

Objectives: The purpose of this study is to examine how meal timing in a one-meal-a-day (OMAD) regimen influences neurocognitive outcomes. Methods: Twelve cognitively active participants (academics, students, software engineers) will complete three randomized OMAD conditions, consuming a standardized isocaloric meal at 08:00, 12:30, or 18:00. ERPs will be recorded during a computerized Stroop task to evaluate peak amplitudes and latencies under congruent and incongruent conditions. Resting-state EEG will be measured under eyes-open and eyes-closed conditions. Behavioral performance on the Stroop task, including reaction time and accuracy, will also be assessed.

Interventions

OTHERone-meal-a-day (OMAD)

Arm Title: Morning Meal (08:00) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 08:00. Arm Title: Midday Meal (12:30) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 12:30. Arm Title: Evening Meal (18:00) Intervention: Other: One-meal-a-day (OMAD) Description: Participants consume a single isocaloric meal at 18:00.

Sponsors

Erzurum Technical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Male, 20 to 45 years of age Right-handed Normal or corrected-to-normal vision Cognitively active individuals (academic staff, graduate students, or software/algorithm engineers) Regular sleep-wake schedule during the week preceding the experiment Ability to abstain from caffeine, alcohol, or psychoactive substances for at least 24 hours prior to each test session Body mass index between 18.5 and 30 kg/m²

Exclusion criteria

History of neurological, psychiatric, metabolic, or sleep disorders Current use of medications that affect the central nervous system Shift work or irregular sleep patterns (verified by sleep diary) Prior experience with one-meal-a-day dietary routines Body mass index below 18.5 or above 30 kg/m²

Design outcomes

Primary

MeasureTime frameDescription
Positive Peak Amplitude of Event-Related Potentials During Stroop - Congruent TrialsDay 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.Maximum voltage deflection (µV) within 250-450 ms after stimulus onset at CP1, CP2, Pz, P3, O1, and O2 electrodes, recorded during congruent Stroop trials using a 32-channel EEG system.
Latency of Positive Peak of Event-Related Potentials During Stroop - Congruent TrialsDay 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.Time point (ms) of maximum positive deflection within 250-450 ms after stimulus onset at CP1, CP2, Pz, P3, O1, and O2 electrodes.

Secondary

MeasureTime frameDescription
Resting-State EEG Absolute Power (Eyes-Open and Eyes-Closed)Day 1 Morning session (09:30-11:00, pre-meal) and Day 1 Afternoon session (14:30-16:00, ~6 hours post-meal). Each participant completes three separate test days (morning, midday, evening feeding), ≥48 hours apart.Broadband spectral power (µV²) recorded at CP1, CP2, Pz, P3, O1, and O2 electrodes during standardized eyes-open and eyes-closed resting-state EEG.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026